3495 -- Opioid and Heroin Abuse Crisis Investment Act of 2017 | Poliscope

Opioid and Heroin Abuse Crisis Investment Act of 2017

3495

115th Congress

Health

In Committee

Legislative Progress

✓

Introduced

Committee

Floor Vote

Other Chamber

Enacted

Introduced

July 27, 2017

Latest Action

July 28, 2017

Primary Sponsor

Ben Ray LujánDemocratic(NM)

Momentum (last 30 days)

score

0 actions · 0 new cosponsors · 0 votes

Speed vs cohort

37pct

1d open

vs 7,393 other HR bills in the 115th — cohort avg 50d

Summary

Opioid and Heroin Abuse Crisis Investment Act of 2017 This bill amends the 21st Century Cures Act to make appropriations for FY2019-FY2023 for state grants to address the opioid abuse crisis. States receiving a grant must report on substance abuse services provided to underserved populations, including Native Americans.

Lobbying filings that explicitly cite this bill (1)

These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.

Filing registrants (1)

VIZCAYA TRADE STRATEGIES (1)

AMERICAN BAR ASSOCIATIONclient→VIZCAYA TRADE STRATEGIES

2018 · fourth_quarter · Copyright/Patent/Trademark

Open original LDA filing ↗

Cited source text, amounts, lobbyists, and targets

S2601/HR 5887 - BIG DATA for IP Act, PTO User Fee Setting Authority; Section 101 of the Patent Act, patent subject matter eligibility; Claim construction standard in Patent Trial and Appeals Board Proceedings; Patent Trial and Appeals Board reform; Diversion of PTO fees/Commerce Department Enterprise Services proposal; Proposed new USPTO Patent Fee Schedule; mandatory e-filing of trademark applications; USPTO guidance on assessing subject matter eligibility; HR 6758/s3483 SUCCESS Act; HR 3495 Copyright Alternative in Small Claims Act of 2017 (CASE Act); S.1010 Register of Copyright Selection and Accountability Act of 2017

Client expense: Not reported · Firm income: $5,156